Insulin was discovered in 1921 and it was not until 1982 when the first commercially available biosynthetic human insulin...
Afrezza Inhaler
The only rapid-acting inhaled insulin, Afrezza, has given insulin-dependent diabetics another option to injections. It allows easy access and administration of the medicine several times a day as needed. Patients would use one of three color-coded strengths and open the mouthpiece to the vertical position and insert the cartridge. The patient would close the mouthpiece, remove the mouthpiece cover and after full exhalation, seal their lips tight around the device and inhale.
Type I and Type II diabetics, who prefer less invasive means of insulin administration and who do not have any contraindications to inhaled medications, now have another option.
Related Topics
Insulin-dependent diabetics require the use of insulin to manage their blood sugar levels. After eating a meal, blood sugar...
